Franklin Resources
ATRA icon

Franklin Resources’s Atara Biotherapeutics ATRA Stock Holding History

Franklin Resources’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-921
Closed -$11.8K – 2874
2023
Q4 		$11.8K Hold
921
– – ﹤0.01% 2595
2023
Q3 		$34.1K Sell
921
-243
-21% -$10.8K ﹤0.01% 2562
2023
Q2 		$46.9K Sell
1,164
-11
-0.9% -$622 ﹤0.01% 2617
2023
Q1 		$85.2K Buy
1,175
+313
+36% +$30.4K ﹤0.01% 2132
2022
Q4 		$70.6K Sell
862
-136
-14% -$14.2K ﹤0.01% 2170
2022
Q3 		$94K Buy
998
+179
+22% +$20.1K ﹤0.01% 2112
2022
Q2 		$159K Sell
819
-398
-33% -$65K ﹤0.01% 2068
2022
Q1 		$283K Sell
1,217
-3
-0.2% -$955 ﹤0.01% 2038
2021
Q4 		$480K Hold
1,220
– – ﹤0.01% 1919
2021
Q3 		$546K Buy
+1,220
New +$437K ﹤0.01% 1850

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return